About Takeda Oncology: Transforming Hope into Action | Takeda Oncology
About Takeda Oncology
We aspire to cure cancer, with inspiration from patients and innovation from everywhere.
Takeda's nearly three decades of leadership in oncology reflect a commitment to advancing treatment options that enhance and extend the lives of people living with a range of cancers.
We're working to ensure that patients everywhere can access and benefit from our portfolio of approved medicines and developing new treatment options for patients with unmet needs. Our pipeline focuses on thoracic, gastrointestinal and hematologic cancers and our core modalities include antibody-drug conjugates (ADCs), complex biologics, small molecules and gamma delta T cell therapies. We see great value in advancing innovation through collaboration with partners who share our aspiration to cure cancer.
Together, we strive to bring life-changing medicines to more patients worldwide.
Takeda Oncology: Aspiring to Cure Cancer
Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company
- Headquarters and R&D center located in Cambridge, Massachusetts.
- Hubs located in 10 countries: Canada, France, Germany, Ireland, Italy, Japan, Portugal, Spain, United Kingdom and the United States.
- Manufacturing centers located in seven countries: Austria, France, Ireland, Italy, Japan, United Kingdom and the United States.
